Cinnamaldehyde Attenuates Cataractogenesis via Restoration of Hypertension and Oxidative Stress in Fructose-Fed Hypertensive rats

  • Singh, Amrita (Department of Pharmacology, SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A Central University)) ;
  • Ahmad Khan, Samsroz (Department of Pharmacology, SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A Central University)) ;
  • Choudhary, Rajesh (Department of Pharmacology, SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A Central University)) ;
  • Bodakhe, Surendra Haribhau (Department of Pharmacology, SLT Institute of Pharmaceutical Sciences, Guru Ghasidas Vishwavidyalaya (A Central University))
  • Received : 2016.04.04
  • Accepted : 2016.05.25
  • Published : 2016.06.30


Objectives: Several studies have revealed that systemic hypertension is strongly associated with cataractogenesis. However, the pathophysiology and treatment is often unclear. In this study, we evaluated the anti-cataractogenic effect of cinnamaldehyde (CA), a natural organic compound, in rats with fructose-induced hypertension. Methods: The rats were divided into six groups. For six weeks, the normal group received a suspension of 0.5% carboxy methyl cellulose (10 mL/kg/day, p.o.) while five other groups received a 10% (w/v) fructose solution in their drinking water to induce hypertension. By the end of the third week hypertension had been induced in all the animals receiving fructose. From the beginning of the fourth week to the end of the sixth week, one of those five groups (control) continued to receive only 10% (w/v) fructose solution, one group (standard) received ramipril (1 mg/kg/day, p.o.) plus 10% (w/v) fructose solution, and three groups (experimental) received CA at doses of 20, 30, and 40 mg/kg/day p.o., plus 10% (w/v) fructose solution. Blood pressure was measured weekly using a non-invasive blood pressure apparatus. After six weeks, the animals were sacrificed, and the anti-cataractogenic effects on the eye lenses were evaluated. Results: Administration of fructose elevated both the systolic and the diastolic blood pressures, which were significantly reduced by CA at all dose levels. In the control group, a significant increase in the malonaldehyde (MDA) level and decreases in the total protein, $Ca^{2+}$adenosine triphosphate (ATP)ase activity, glutathione peroxidase, catalase, superoxide dismutase and glutathione levels, as compared to the normal group, were observed. Administration of CA at all doses significantly restored the enzymatic, non-enzymatic, antioxidants, total protein, and $Ca^{2+}$ATPase levels, but decreased the MDA level, as compared to the control group. Conclusion: The present study revealed that CA modulated the antioxidant parameters of the serum and lens homogenates in hypertension-induced cataractogenic animals.


  1. Lira RP, Nascimento MA, Arieta CEL, Duarte LE, Hirata FE, Nadruz W. Incidence of preoperative high blood pressure in cataract surgery among hypertensive and normotensive patients. Indian J Opthalmol. 2010;58(6):493-5.
  2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23.
  3. Lin L, Lv S, Li B. Angiotensin-I-converting enzyme (ACE)-inhibitory and antihypertensive properties of squid skin gelatin hydrolysates. Food Chem. 2012;131(1):225-30.
  4. Mukesh BN, Le A, Dimitrov PN, Ahmed S, Taylor HR, McCarty CA. Development of cataract and associated risk factors. Arch Ophthalmol. 2006;124(1):79-85.
  5. Rim TH, Kim MH, Kim WC, Kim TI, Kim EK. Cataract subtype risk factors identified from the Korea national health and nutrition examination survey 2008-2010. BMC Ophthalmol. 2014;14:DOI: 10.1186/1471-2415-14-4.
  6. Tsai SY, Hsu WM, Cheng CY, Liu JH, Chou P. Epidemiologic study of age-related cataracts among an elderly Chinese population in Shih-Pai, Taiwan. Ophthalmology. 2003;110(6):1089-95.
  7. Yu X, Lyu D, Dong X, He J, Yao K. Hypertension and risk of cataract: a meta-analysis. PloS one. 2014;9(12):DOI: 10.1371/journal.pone.0114012.
  8. Wong TY, Mitchell P. The eye in hypertension. Lancet. 2007;369(9559):425-35.
  9. Bautista LE, Vera LM, Arenas IA, Gamrara G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertension. 2005;19(2):149-54.
  10. Schaumberg DA, Ridker PM, Glynn RJ, Christen WG, Dana MR, Hennekens CH. High levels of plasma C-reactive protein and future risk of age-related cataract. Ann Epidemiol. 1999;9(3):166-71.
  11. Lee SM, Lin SY, Li MJ, Liang RC. Possible mechanism of exacerbating cataract formation in cataractous human lens capsules induced by systemic hypertension or glaucoma. Ophthalmic Res. 1997;29(2):83-90.
  12. Klein AV, Kiat H. The mechanisms underlying fructose-induced hypertension: a review. J Hypertens. 2015;33(5):912-20.
  13. Balasaraswathi K, Rajasekar P, Anuradha CV. Changes in redox ratio and protein glycation in precataractous lens from fructose-fed rats: effects of exogenous L-carnitine. Clin Exp Pharmacol Physiol. 2008;35(2):168-73.
  14. Mang B, Wolters M, Schmitt B, Kelb K, Lichtinghagen R, Stichtenoth DO, et al. Effects of a cinnamon extract on plasma glucose, HbA1c and serum lipids in diabetes mellitus type 2. Eur J Clin Invest. 2006;36(5):340-4.
  15. Mahfouz MH, Ghanem HM, Mohamed MA. Therapeutic effect of L-carnitine on sialic acid, soluble Fas (sFas) and other biochemical variables in hyperinsulinemic rats. Life Sci J. 2009;6(2):76-82.
  16. El-Bassossy HM, Fahmy A, Badawy D. Cinnamaldehyde protects from the hypertension associated with diabetes. Food Chem Toxicol. 2011;49(11):3007-12.
  17. Chang ST, Chen PF, Chang SC. Antibacterial activity of leaf essential oils and their constituents from Cinnamomum osmophloeum. J Ethnopharmacol. 2001;77(1):123-7.
  18. Chao LK, Hua KF, Hsu HY, Cheng SS, Lin IF, Chen CJ, et al. Cinnamaldehyde inhibits pro-inflammatory cytokines secretion frommonocytes/macrophages through suppression of intracellular signaling. Food Chem Toxicol. 2008;46(1):220-31.
  19. Youn HS, Lee JK, Choi YJ, Saitoh SI, Miyake K, Hwang DH, et al. Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. Biochem Pharmacol. 2008;75(2):494-502.
  20. Zhang W, Xu YC, Guo FJ, MengY, Li ML. Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4expression in rats with type 2 diabetes mellitus. Chin Med J (Engl). 2008;121(21):2124-8.
  21. Lee HS. Inhibitory activity of Cinnamomum cassia bark-derived component against rat lens aldose reductase. J Pharm Pharm Sci. 2002;5(3):226-30.
  22. Dai S, McNeil JH. Fructose-induced hypertension in rats is concentration and duration dependent. J Pharmacol Toxicol Methods. 1995;33(2):101-7.
  23. Son HY, Kim H, H Kwon Y. Taurine prevents oxidative damage of high glucose – induced cataractogenesis in isolated rat lenses. J Nutr Sci Vitaminol. 2007;53(4):324-30.
  24. Tappel AL. Glutathione peroxidase and hydroperoxides. Methods Enzymol. 1978;52(53):506-13.
  25. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-6.
  26. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984;21(2):130-2.
  27. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70-7.
  28. Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxide in animal tissue by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351-8.
  29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem. 1951;193(1):265-75.
  30. Rorive G, Kleinzeller A. $Ca2^+$-Activated ATPase from renal tubular cells. Methods Enzymol. 1974;32(28):303-6.
  31. de Champlain J, Wu R, Girouard H, Karas M, EL Midaoui A, Laplante MA, et al. Oxidative stress in hypertension. Clin Exp Hypertens. 2004;26(7-8):593-601.
  32. Redon J, Oliva MR, Tormos C, Giner V, Chaves J, Iradi A, et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension. 2003;41(5):1096-101.
  33. Dimo T, Rakotonirina SV, Tan PV, Azay J, Dongo E, Cros G. Leaf methanol extract of Bidens pilosa prevents and attenuates the hypertension induced by high-fructose diet in Wistar rats. J Ethnopharmacol. 2002;83(3):183-91.
  34. Khitan Z, Kim DH. Fructose: a key factor in the development of metabolic syndrome and hypertension. J Nutr Metab. 2013;2013:DOI: 10.1155/2013/682673.
  35. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615-25.
  36. Rebolledo OR, Marra CA, Raschia A, Rodriguez S, Gagliardino JJ. Abdominal adipose tissue: early metabolic dysfunction associated to insulin resistance and oxidative stress induced by an unbalanced diet. Horm Metab Res. 2008;40(11):794-800.
  37. Gersch MS, Mu W, Cirillo P, Reungjui S, Zhang L, Roncal C, et al. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal physiol. 2007;293(4):1256-61.
  38. Rajasekar P, Anuradha CV. Effect of L-carnitine on skeletal muscle lipids and oxidative stress in rats fed high-fructose diet. Exp Diabetes Res. 2007;2007:72741.
  39. Guglielmotto M, Aragno M, Tamagno E, Vercellinatto I, Visentin S, Medana C, et al. AGEs/RAGE complex upregulates BACE1 via NF-kappa B pathway activation. Neurobiol Aging. 2012;33(1):13-27.
  40. Lyle BJ, Mares-Periman JA, Klein BE, Klein R, Greger JL. Antioxidant intake and risk of incident age-related nuclear cataracts in the beaver dam eye study. Am J Epidemiol. 1999;149(9):801-9.
  41. Takagi Y, Kashiwagi A, Tanaka Y, Ashahin T, Kikkawa R, Shigeta Y. Significance of fructose-induced protein oxidation and formation of advanced glycation end product. J Diabetes Complications. 1995;9(2):87-91.
  42. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158-69.
  43. Shearer TR, Azuma M, David LL, Murachi T. Amelioration of cataracts and proteolysis in cultured lenses by cysteine protease inhibitor E64. Invest Ophthalmol Vis Sci. 1991;32(3):533-40.
  44. Awasthi S, Srivatava SK, Piper JT, Singhal SS, Chaubey M, Awasthi YC. Curcumin protects against 4-hydroxy-2-trans-nonenal-induced cataract formation in rat lenses. AM J Clin Nutr. 1996;64(5):761-6.
  45. Grattagliano I, Vendemiale G, Boscia F, Micelli-Ferrari T, Cardia L, Altomare E. Oxidative retinal products and ocular damages in diabetic patients. Free Radic Biol Med. 1998;25(3):369-72.
  46. Gupta PD, Johar K, Vasavada A. Causative and preventive action of calcium in cataracto-genesis. Acta Pharmacol Sin. 2004;25(10):1250-6.
  47. Liu L, Paterson CA, Borchman D. Regulation of sarco/endoplasmic $Ca2^+$-ATPase expression by calcium in human lens cells. Exp Eye Res. 2002;75(5):583-90.
  48. Bodakhe SH, Ram A, Verma S, Pandey DP. Anticataract activity of rhamnocitrin isolated from Bauhinia variegata stem bark. Orient Pharm Exp Med. 2012;12(3):227-32.
  49. Jung HA, Islam MD, Kwon YS, Jin SE, Son YK, Park JJ, et al. Extraction and identification of three major aldose reductase inhibitors from Artemisia montana. Food Chem Toxicol. 2011;49(2):376-84.
  50. Lee AY, Chung SK, Chung SS. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Natl Acad Sci USA. 1995;92(7):2780-4.
  51. Lee HS. Inhibitory activity of Cinnamomum cassia bark-derived component against rat lens aldose reductase. J Pharm Pharm Sci. 2002;5(3):226-30.

Cited by

  1. Magnesium taurate prevents cataractogenesis via restoration of lenticular oxidative damage and ATPase function in cadmium chloride-induced hypertensive experimental animals vol.84, 2016,
  2. Olmesartan, an angiotensin II receptor blocker inhibits the progression of cataract formation in cadmium chloride induced hypertensive albino rats vol.167, 2016,
  3. -induced skeletal muscle atrophy by ameliorating the proteolytic and antioxidant defense systems pp.00219541, 2018,
  4. Role of Nitric Oxide in the Development of Cataract Formation in CdCl2-induced Hypertensive Animals pp.1460-2202, 2018,
  5. S-Allylmercapro-N-Acetylcysteine Attenuates the Oxidation-Induced Lens Opacification and Retinal Pigment Epithelial Cell Death In Vitro vol.8, pp.1, 2019,